# Sijin Wen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sijin-wen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 15,336 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 64 |
| i10-index | 189 |
| Last Known Institution | West Virginia University |
| OpenAlex ID | https://openalex.org/A5040146877 |
| ORCID iD | 0000-0002-6955-2917 |
| Works | 531 |

## Researcher papers

- [Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia](https://scholariq.org/papers/long-term-results-of-the-fludarabine-cyclophosphamide-and-rituximab-regimen-as/)
- [Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative](https://scholariq.org/papers/personalized-medicine-in-a-phase-i-clinical-trials-program-the-md-anderson/)
- [Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia](https://scholariq.org/papers/chemoimmunotherapy-with-fludarabine-cyclophosphamide-and-rituximab-for-relapsed/)
- [CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma](https://scholariq.org/papers/cd8-tumor-infiltrating-lymphocytes-are-predictive-of-survival-in-muscle-invasive/)
- [Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance](https://scholariq.org/papers/phase-ii-trial-of-infusional-fluorouracil-irinotecan-and-bevacizumab-for/)
- [Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer](https://scholariq.org/papers/platinum-based-chemotherapy-for-variant-castrate-resistant-prostate-cancer/)
- [Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia](https://scholariq.org/papers/lenalidomide-induces-complete-and-partial-remissions-in-patients-with-relapsed/)
- [Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study](https://scholariq.org/papers/neoadjuvant-paclitaxel-ifosfamide-and-cisplatin-chemotherapy-for-metastatic/)
- [Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience](https://scholariq.org/papers/multimodality-management-of-urachal-carcinoma-the-m-d-anderson-cancer-center/)
- [Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation](https://scholariq.org/papers/clinical-outcomes-and-prognostic-factors-in-patients-with-richter-s-syndrome/)
- [Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines](https://scholariq.org/papers/environmental-perfluoroalkyl-acid-exposures-are-associated-with-liver-disease/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [West Virginia University](https://scholariq.org/institutions/west-virginia-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.